Matthias Philipp Müller

Matthias Philipp Müller

Auto-generated profile, based on publicly available information

Matthias Philipp Müller

Department of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn-Straße 4a, Dortmund, Germany, 44227

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2010 in Science
Verified
Journal Article
Closed access
PDF file
MMMatthias P. Müller
Matthias P. Müller
HPHeide Peters
Heide Peters
JBJulia Blümer
Julia Blümer
WBWulf Blankenfeldt
Wulf Blankenfeldt
RGRoger S. Goody
Roger S. Goody
AIAymelt Itzen
Aymelt Itzen
Legionella Hijacks Rab: Legionella pneumophila can infect eukaryotic cells and takes up residence within intracellular vacuoles, where it multiplies. In order to produce and maintain this intracellular niche, the pathogen must manipulate membrane trafficking within the host cell. Now, Müller et al. (p. 946 , published online 22 July) describe the ability of Legionella pneumophila to manipulate vesicular trafficking by the covalent modification of the small guanosine triphosphatase (GTPase) Rab1, which normally regulates the transport of endoplasmic reticulum–derived vesicles in eukaryotic cells. The Legionella protein DrrA is released into the cytosol of infected cells, where it specifically AMPylates a tyrosine residue of one of the regulating regions of Rab1. The modification renders the Rab protein inaccessible to GTPase-activating proteins and thus locks it in its active guanosine triphosphate–bound state.

1 February 2017 in Small GTPases
Verified
Journal Article
Open access
MMMatthias P. Müller
Matthias P. Müller
RGRoger S. Goody
Roger S. Goody
Rab proteins are the major regulators of vesicular trafficking in eukaryotic cells. Their activity can be tightly controlled within cells: Regulated by guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs), they switch between an active GTP-bound state and an inactive GDP-bound state, interacting with downstream effector proteins only in the active state. Additionally, they can bind to membranes via C-terminal prenylated cysteine residues and they can be solubilized and shuttled between membranes by chaperone-like molecules called GDP dissociation inhibitors (GDIs). In this review we give an overview of Rab proteins with a focus on the current understanding of their regulation by GEFs, GAPs and GDI.

1 June 2020 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
LGLisa Goebel
Lisa Goebel
MMMatthias P. Müller
Matthias P. Müller
RGRoger S. Goody
Roger S. Goody
DRDaniel Rauh
Daniel Rauh
Short historical perspective of the development of promising KRasG12C inhibitors that have recently entered clinical trials.

3 February 2012 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
PGPhilip R Goody
Philip R Goody
KHKatharina Heller
Katharina Heller
LOLena K Oesterlin
Lena K Oesterlin
MMMatthias P Müller
Matthias P Müller
AIAymelt Itzen
Aymelt Itzen
RGRoger S Goody
Roger S Goody

23 August 2016 in eLife
Verified
Journal Article
Open access
Amrita RaiAmrita Rai
Amrita Rai
AOAnastasia Oprisko
Anastasia Oprisko
JCJeremy Campos
Jeremy Campos
YFYangxue Fu
Yangxue Fu
TFTimon Friese
Timon Friese
MMMatthias P Müller
Matthias P Müller
In their active GTP-bound form, Rab proteins interact with proteins termed effector molecules. In this study, we have thoroughly characterized a Rab effector domain that is present in proteins of the Mical and EHBP families, both known to act in endosomal trafficking. Within our study, we show that these effectors display a preference for Rab8 family proteins (Rab8, 10, 13 and 15) and that some of the effector domains can bind two Rab proteins via separate binding sites. Structural analysis allowed us to explain the specificity towards Rab8 family members and the presence of two similar Rab binding sites that must have evolved via gene duplication. This study is the first to thoroughly characterize a Rab effector protein that contains two separate Rab binding sites within a single domain, allowing Micals and EHBPs to bind two Rabs simultaneously, thus suggesting previously unknown functions of these effector molecules in endosomal trafficking.

17 August 2012 in Traffic
Verified
Journal Article
Open access
PDF file
MSMary‐Pat Stein
Mary‐Pat Stein
MMMatthias P. Müller
Matthias P. Müller
Angela Wandinger-NessAngela Wandinger-Ness
Angela Wandinger-Ness
Intracellular bacterial pathogens deploy virulence factors termed effectors to inhibit degradation by host cells and to establish intracellular niches where growth and differentiation take place. Here, we describe mechanisms by which human bacterial pathogens (including Chlamydiae; Coxiella burnetii; Helicobacter pylori; Legionella pneumophila; Listeria monocytogenes; Mycobacteria; Pseudomonas aeruginosa, Salmonella enterica) modulate endocytic and exocytic Rab GTPases in order to thrive in host cells. Host cell Rab GTPases are critical for intracellular transport following pathogen phagocytosis or endocytosis. At the molecular level bacterial effectors hijack Rab protein function to: evade degradation, direct transport to particular intracellular locations and monopolize host vesicles carrying molecules that are needed for a stable niche and/or bacterial growth and differentiation. Bacterial effectors may serve as specific receptors for Rab GTPases or as enzymes that post‐translationally modify Rab proteins or endosomal membrane lipids required for Rab function. Emerging data indicate that bacterial effector expression is temporally and spatially regulated and multiple virulence factors may act concertedly to usurp Rab GTPase function, alter signaling and ensure niche establishment and intracellular bacterial growth, making this field an exciting area for further study.